We conducted subgroup analyses to further validate whether factors such as age, sex, hypertension, CAD, ACS, or HF could have influenced the association between elevated cTnT and NT-proBNP levels and long-term cardiovascular outcomes. This evidence concerns the gene TNNT2 and hypertensive disorder.